This is a preview of subscription content, log in via an institution to check access.
Notes
proportion of glycosylated haemoglobin
Reference
Baptista A, et al. The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies. European Journal of Health Economics : 17 Oct 2016. Available from: URL: http://dx.doi.org/10.1007/s10198-016-0837-7
Rights and permissions
About this article
Cite this article
DPP-4 inhibitors cost effective for second-line T2DM treatment. PharmacoEcon Outcomes News 765, 14 (2016). https://doi.org/10.1007/s40274-016-3499-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3499-x